Skip to Content

barr 250mg 589 (Didanosine 250 mg)

Pill with imprint barr 250mg 589 is Blue & White, Capsule-shape and has been identified as Didanosine 250 mg. It is supplied by Teva Pharmaceuticals USA.

Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for barr 250mg 589

Didanosine

Imprint
barr 250mg 589
Strength
250 mg
Color
Blue & White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
ferrosoferric oxide, croscarmellose sodium, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), hypromellose 2910 (50 mPa.s), methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, polydextrose, polyethylene glycol 8000, propylene glycol, shellac, silicon dioxide, sodium hydroxide, magnesium silicate, titanium dioxide, triacetin, triethyl citrate, D&C Red No. 28

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00555-0589 Barr Laboratories, Inc.
54569-5642 A-S Medication Solutions, LLC (repackager)
54868-5464 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.